NeoImmuneTech, Inc.

1 open jobs

NeoImmuneTech is a clinical-stage, T cell-focused biopharmaceutical company founded in 2014 that investigates immuno-oncology therapies and treatments for infectious diseases, with a lead product candidate NT-I7 and commercial operations around Endari®, an FDA-approved therapy for sickle cell disease.